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Abstract
Diffuse white matter (WM) disease is highly prevalent in elderly with cerebral small vessel disease 
(cSVD). In humans, cSVD such as cerebral amyloid angiopathy (CAA) often coexist with 
Alzheimer’s disease imposing a significant impediment for characterizing their distinct effects on 
WM. Here we studied the burden of age-related CAA pathology on WM disease in a novel 
transgenic rat model of CAA type 1 (rTg-DI). A cohort of rTg-DI and wild type rats was scanned 
longitudinally using MRI for characterization of morphometry, cerebral microbleeds (CMB) and 
WM integrity. In rTg-DI rats a distinct pattern of WM loss was observed at 9M and 11M. MRI 
also revealed manifestation of small CMB in thalamus at 6M, which preceded WM loss and 
progressively enlarged until the moribund disease stage. Histology revealed myelin loss in the 
corpus callosum and thalamic CMB in all rTg-DI rats, the latter of which manifested in close 
proximity to occluded and calcified microvessels. The quantitation of CAA load in rTg-DI rats 
revealed that the most extensive microvascular Aβ deposition occurred in the thalamus. For the 
first time using in vivo MRI, we show that CAA type 1 pathology alone is associated with a distinct 
pattern of WM loss. 
Key words: Cerebral amyloid angiopathy; transgenic rat; microbleed, DTI, white matter
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Introduction
Compelling clinical evidence implicates a major role of cerebral small vessel disease (cSVD) in 
vascular cognitive impairment and dementia (VCID).1 cSVD are disorders caused by pathologies 
of the small blood vessels in the brain.2-5 cSVD contributes to and worsens Alzheimer’s disease 
(AD) symptoms6 and triples the risk of stroke.7, 8 The underlying pathogenesis of cSVD is still 
poorly understood and no effective preventive or curative treatments currently exist.9 cSVD are 
diagnosed by distinct pathologies detected by magnetic resonance imaging (MRI) including white 
matter (WM) hyperintensities, diffuse WM loss, enlarged perivascular spaces (ePVS), lacunar 
infarcts, cerebral microbleeds (CMB), microinfarcts and global brain atrophy.5, 10-13 
Several different subtypes of cSVD that often overlap in human brain are observed based 
on the cerebral vessel bed impacted.14 The most common cSVD subtypes are arteriolosclerosis, 
cerebral small vascular atherosclerosis and cerebral amyloid angiopathies.4, 15-17 Sporadic cerebral 
amyloid angiopathy (CAA) is the second most common cSVD subtype in the elderly and is 
characterized by the presence of fibrillar amyloid-beta protein (Aβ) deposits in the vessel walls of 
meninges, cerebral arteries, arterioles and capillaries. The age-related prevalence rates of CAA are 
>50% over 80 years.15, 18, 19 CAA manifests as two distinct pathologies designated as CAA type 1 
and CAA type 2.20 CAA type 1 is characterized by the Aβ deposition in the capillaries causing 
dyshoric angiopathy and a strong neuroinflammatory response.21-23 In contrast, CAA type 2 is 
characterized by Aβ deposition within the vessel walls of cortical and meningeal arteries and 
arterioles.24 The extensive and chronic vascular Aβ deposition in late-stage CAA is associated with 
CMB, larger lobar hemorrhages or focal ischemic insults.23, 25-27 
Presently, the Boston criteria provides a ‘probable’ diagnosis of CAA based on the 
demonstration of multiple hemorrhages restricted to lobar, cortical or cortical-subcortical regions 
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by imaging.28-30 Although the two different CAA subtypes are well-recognized in post-mortem 
human brain20 their contribution to diffuse WM disease is unknown because they commonly co-
exist with AD and cannot be studied in isolation.31-36 Thus, despite the high prevalence of WM 
disease in cSVD and its significance for VCID there is a gap in knowledge regarding its 
progression over time and how it relates to burden of CAA pathology including CMB.
Transgenic mouse cSVD models that develop CAA type 1 or CAA type 2 without other 
overlapping cSVD pathologies (e.g. hypertensive vasculopathies or AD)24, 37-40 have provided 
valuable insights into understanding how cerebral vascular amyloid, CMB and other 
pathophysiology relate to cognitive dysfunction as the disease progresses. However, thus far 
diffuse WM disease has not been reported in CAA mouse models which brings into question their 
relevance for human cSVD. Recently we introduced a novel CAA transgenic rat model that 
expresses chimeric Dutch/Iowa familial CAA mutant Aβ in brain (rTg-DI) and develops age-
dependent deposition of capillary Aβ, perivascular neuroinflammation, CMB and behavioral 
deficits.40 The new rTg-DI rat model now allows further investigation into how the evolving CAA 
type 1 pathology impacts WM in the live brain by MRI. In this study, the evolution of CMB and 
brain morphometry were characterized longitudinally in a cohort of rTg-DI rats from early stage 
disease at 3-month (M) of age until rTg-DI became moribund (~11M). The in vivo MRI findings 
were validated by in vitro 3D diffusion tensor imaging (DTI) as well as histological measures of 
WM loss, CAA load and CMB. The ultimate goal of these experiments is to inform on the burden 
of age-related CAA type 1 pathology in relation to WM disease and ultimately to future efforts 
addressing VCID in CAA.
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Material and Methods
Animal, strains and genotyping
All animal experiments were approved by the Institutional Animal Care and Use Committees at 
Yale University and University of Rhode Island and conducted in accordance with the United 
States Public Health Service’s Policy on Humane Care and Use of Laboratory Animals and the 
experiments have been reported in compliance with the ARRIVE guidelines. The rTg-DI CAA 
type 1 rat line expresses human Swedish/Dutch/Iowa vasculotropic mutant amyloid-beta precursor 
protein (AβPP) under control of the neuronal Thy1.2 promoter and produces chimeric Dutch/Iowa 
CAA mutant Aβ peptides in brain.40 Heterozygous transgenic offspring of rTg-DI rats were used, 
and all transgenic rats were confirmed for the human AβPP transgene by genotyping. In vivo MRI 
experiments were conducted longitudinally on the same cohorts of WT and rTg-DI female rats at 
3M, 6M, 9M, and until they were severely impacted by CAA type 1 disease and became moribund 
(as evidenced by rapid >10-20% weight loss compared to control loss which occurred ∼11M of 
age in rTg-DI rats). In addition, we also included separate groups of female and male rTg-DI and 
WT rats ranging from 3-11M for in vitro WM characterization by DTI. All MRI acquisitions were 
performed on a Bruker 9.4T/16cm bore MRI instrument with a BGA-9S-HP imaging gradient 
interfaced to a Bruker Avance III console and controlled by Paravision 6.1 software (Bruker Bio 
Spin, Billerica, MA, USA). A volume RF transmit and receive head only coil with an inner 
diameter of 4.0 cm was utilized for both in vivo and in vitro MRI scans. During the scans anesthesia 
was maintained with dexmedetomidine (0.015-0.020 mg/kg/hr via a subcutaneous catheter) 
supplemented with 0.5-0.8 % isoflurane delivered in a 1:1 Air:O2 mixture.41 The stability of 
anesthetic plane was assessed by means of continuous measurement of heat rate and blood oxygen 
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saturation (SpO2) during the scanning. SpO2 was kept in the range of 97-100% during scanning. 
Body temperature was kept in the range of 36-37oC using a heated waterbed.
In vivo MRI sequences 
For morphometric scans a proton-density weighted (PDW) 3D spoiled gradient echo sequence was 
used with the following parameters: Repetition time (TR) = 50 ms; echo time (TE) = 4 ms; flip 
angle = 7o; number of signal averages (NA) = 4, total scan time = 27 min. A saturation pulse was 
applied ventral to the lower jaw to prevent image aliasing artifact within the field of view (30 mm 
x 30 mm x 15 mm) allowing for an isotropic spatial resolution of 0.23 mm x 0.23 mm x 0.23 mm. 
Following the PDW scan, a 3D multiple gradient echo (MGE) sequence (T2*-weighted) was 
acquired for CMB detection with the same spatial resolution (0.23 mm x 0.23 mm x 0.23 mm) and 
orientation  as the PDW image using following parameters: TR =  60 ms; TE = 2 ms,12 ms, 22 ms, 
32 ms; flip angle = 15; NA = 6 yielding a total scanning time of 49 min. 
In vitro DTI imaging
The signal intensity on PDW images varies across the brain, which facilitates the anatomical 
segmentation into three tissue compartments: GM, WM and cerebrospinal fluid (CSF). In the 
setting of pathological changes (e.g. CMB or tissue degeneration) erroneous tissue segmentation 
based on anatomical image contrast could in principle occur. Therefore, to further validate the 
morphometry-based assessment of WM changes we also implemented DTI imaging in separate 
series of rats. Accordingly, in vitro MRI scans were performed on an additional series of WT and 
rTg-DI rats at 3M, 6M, 8M, and 11 M using the active gadolinium staining technique.42, 43 
Following an overdose of ketamine (~130mg/kg) rats underwent transcardial perfusion fixation 
with a mixture of phosphate buffer 4% paraformaldehyde solution (SF-100 Fischer Scientific) 
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containing 5% (50 mM) Gadoteric acid (Gd-DOTA Guerbet LLC, Princeton, NJ, USA) delivered 
by a servo-controlled peristaltic pump (Masterflex Peristaltic Tubing Pumps, Cole-Parmer, Vernon 
Hills, IL, USA). Prior to imaging, the specimens were allowed to reach a room temperature (19-
21oC) before being placed in a custom-made MRI-compatible holder containing proton signal-free 
susceptibility matched fluid (Galden Heat Transfer Fluids, HT230. Kurt J. Lesker, Company, 
USA). A 3D pulsed gradient spin-echo DTI imaging protocol was implemented using following 
parameters: TR = 350 ms; TE = 20 ms; NA = 1; diffusion time = 4 ms; gradient duration = 10 ms; 
isotropic voxel resolution of 156 µm x 156 µm x 156 µm. One non-diffusion weighted image (b = 
20 s/mm2) image and 6 diffusion weighted images (b = 2500 s/mm2) were acquired along 6 non-
collinear diffusion gradient vectors: [1, 1, 0], [1, 0, 1], [0, 1, 1], [-1, 1, 0], [1, 0, -1], and [0, -1, 1] 
requiring a total acquisition time of 11 h 9 min per specimen. 
In vivo MR imaging analyses
Analyses of in vivo MRI data included characterizing morphometric and T2* differences between 
rTg-DI and WT rats at the four time points (3M, 6M, 9M and 11M). PDW image analysis: The 
PDW images were used for voxel-based morphometry (VBM) to characterize the age-dependent 
morphometric voxel-wise differences between rTg-DI and WT groups. For this purpose, image 
registration and subsequent voxel-wise statistical analyses were performed using SPM12 
(http://www.fil.ion.ucl.ac.uk/spm) as previously described44-46 using custom-made GM, WM and 
CSF tissue probability maps (TPMs) (Supplementary Figure 1).44, 47, 48 Spatial registration 
parameters between TPMs and individual scans were calculated using the DARTEL algorithm and 
subsequently smoothed by a 0.6 mm Gaussian smoothing kernel. Voxel-wise statistical analysis 
was performed by a two-sample t-test with total intracranial volume (TIV) as a covariate and 
statistical significance was reported at p-value<0.05 after correcting for multiple comparison by 
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false discovery rate (FDR). T2* analysis: A relationship between a MGE signal as a function of 
echo time is complex and studies have reported non-mono exponential decay49, which require data 
collection over many TEs. In this study we instead implemented the commonly performed mono-
exponential decay as the first approximation. Thus, the 3D T2* maps were calculated from the 
MGE data by assuming mono-exponential signal decay between the detected signals and the echo 
times. The signals were log transformed and fitted as a function of the echo times using a linear 
least square fit algorithm. To spatially register the T2* maps onto the anatomical PDW templates 
the spatial transformation parameters estimated for the VBM analysis was used. Following this 
processing step, the T2* map was smoothed with an isotropic Gaussian kernel of 0.6 mm. A two-
sample t-test was performed and voxel-wise differences for T2* was considered statistically 
significant at p-value < 0.05 after correcting for multiple comparison by FDR. For both VBM and 
T2* map images, the voxel-wise analyses were executed separately, at each scan point (3M, 6M, 
9M and 11M). The T2* maps were also used for estimating the trajectory of CMB ‘load’ and 
volume changes in the thalamus over time in rTg-DI rats compared to WT rats. For this purpose, 
a thalamic ROI was overlaid onto the T2* maps and the mean T2* value was extracted for each 
rat at each scan time point. T2* values ≤ 20 ms within the thalamus was identified on the parametric 
T2* maps in each rat using the Amira software segmentation editor (Amira 6.4, ThermoFisher 
Scientific). The setting of the T2* threshold of ≤ 20ms to quantify the thalamic CMB were 
determined based on two experienced imagers’ (HB and HL) assessment of ‘best match’ with the 
well-defined low intensity regions observed bilaterally in the thalamus. The number of voxels with 
T2* ≤ 20 ms was converted into mm3 and used as an estimate of ‘total hemorrhagic load’ in the 
thalamus. 
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In vitro DTI imaging analyses: 
In vitro DTI image analyses were performed at both mesoscopic (whole brain, anatomical regions 
of interest) and microscopic (voxel-wise) scales. First, voxel-wise tensor maps were calculated 
using the diffusion software toolbox (http://www. fmrib.ox.ac.uk/fsl/).50 Second, 3D voxel-wise 
tensor maps were spatially normalized by using the DTI-TK diffeomorphic deformable image 
registration algorithm (https://www.nitrc.org/projects/dtitk).51, 52 Finally, fractional anisotropy 
(FA), was calculated in the spatially normalized space for each subject. 
Voxel-wise statistical analyses were performed after smoothing the spatially normalized 
DTI indices by a 0.4 mm Gaussian smoothing kernel. A two-sample t-test was performed for 
animals in each age group using SPM12. A voxel was considered statistically significant at p-value 
< 0.05 after correcting for multiple comparison by FDR. Characterization of anatomically defined 
regions of interest (ROI) was performed using deterministic streamline fiber tractography.53 
Connectivity of WM tracts within corpus callosum (CC), anterior commissure (AC), and the 
projection fibers from CC to frontal cortex (FC) were manually delineated. ROIs were delineated 
by using whole-brain population averaged fiber tracts (Supplementary Figure 2). In addition, an 
image plane orthogonal to the long axis of the structure was created in evaluating the 2D slice 
profile of FA. 
Immunohistochemical analyses: 
All rats in the longitudinal MRI scan series underwent histological analysis for detection of fibrillar 
amyloid, neuroinflammation and CMB. Immunohistochemistry and histology were performed as 
previously described and detailed in the supplemental method.40, 54-56 
Statistical analysis: 
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The data are presented as mean estimates or differences of means for the tissue compartment 
outcomes with standard deviations (SD) for univariate summaries or standard errors (SE) 
otherwise. Designed experiments that yielded one measurement per rat were analyzed using linear 
regression analysis. For experiments with repeated measurements on each animal, we used a 
Generalized Estimating Equations (GEE) to account for repeated measures correlations. All 
hypotheses were tested using Wald test statistics. Pairwise comparisons between the two strains at 
each age were investigated. The p-values were not adjusted for multiple comparisons. All 
hypothesis tests and 95 % confidence intervals (CI) are two-sided. Analyses were performed using 
the Stata (version 16.1) statistical package. Additional statistical analysis was carried out using 
XLSTAT statistical and data analysis solution. (Boston, USA. https://www.xlstat.com). Cohen’s 
d was also calculated in the voxel-wise analyses as a measure of effect size.57, 58
Results
In all anesthetized rats, oxygen saturation (SpO2) and heart rate were measured continuously 
during the ~1h MRI scan and these data for each of the four scan sessions are presented in the 
Supplementary Figure 3. Statistical analysis on the influence of age and strain on SpO2 rate at the 
beginning (5-min) and end of the scans (55-min) revealed no differences across strains for either 
time point. For heart rate measures at the end of the scan, differences were significant for the 
variables age (p-value < 0.0001) and strain (p-value < 0.004) indicating that rTg-DI rats were 
hemodynamically more sensitive to the effect of anesthesia.
CAA type 1 pathology accelerates age-dependent white matter loss 
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Volumes for GM, WM and CSF tissue compartments of rTg-DI and WT rats at 3M, 6M, 9M and 
11M age points are summarized in Supplementary Table 1. For TIV, there was no significant 
differences between WT and rTg-DI rats as noted in the p-values for the tests of pairwise 
differences. For the GM compartment the statistical analysis revealed no volumetric differences 
between strains at any age. However, an overall ~10% GM volume loss was documented from 3M 
to 11M in both strains. (p-value < 0.001, Supplementary Table 1 and Figure 1). The temporal 
profiles of WM volume from rTg-DI and WT rats differed across the four age groups (p-value < 
0.001) and is also reflected in the four pairwise differences (Supplementary Table 1, p-values < 
0.001). Figure 1 shows the WM volume changes as a function of age and illustrates that the rTg-
DI and WT rats diverge between 6M and 9M, with a pairwise mean difference of -51.7 mm3 (95% 
CI = [-72.7, -30.7] cm3, p-value < 0.001). Note also, that the difference between the age-dependent 
WM volume profiles is largest at 11M (mean difference = -74.5 mm3 (95% CI = [-95.7, -53.4] 
cm3, p-value < 0.001) (Supplementary Table 1). 
VBM analyses were performed at the designated ages of 3M, 6M, 9M and 11M to further 
characterize the spatial distribution of local morphological differences between WT and rTg-DI 
rats. VBM analysis revealed no GM volume differences betwe n WT and rTg-DI rats at any age 
(Supplementary Figure 4). However, the VBM analysis on WM revealed striking strain differences 
as shown in Supplementary Figure 5. Note that in both WT and rTg-DI rats global volumetric WM 
maturational growth is apparent from 3M to 6M in agreement with the quantitative data 
(Supplementary Table 1 and Figure 1). While in the WT rats, WM density appeared constant from 
6M to 11M, rTg-DI rats exhibited extensive, diffuse WM volume loss at 9M and 11M 
(Supplementary Figure 5). To further validate the descriptive VBM analysis, statistical parametric 
maps (color coded for p-values) were overlaid onto a population averaged PDW images to display 
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areas with significant morphological differences between the two strains (Figure 2). At 3M, only 
a few small clusters were observed to be smaller in rTg-DI compared to WT rats. However, at 6M, 
significant WM loss was apparent in the CC, and the deep mesencephalic nuclei of rTg-DI when 
compared to WT control rats. Furthermore, at 9M and 11M, WM loss in rTg-DI rats was 
widespread and included the entire body of the CC, AC and internal capsule. In addition, WM loss 
in rTg-DI rats was also notable in the in globus pallidus, thalamus, and the central tegmental tract 
compared to WT rats. No voxels survived the statistical significance in the direction of WM 
volume greater in rTg-DI compared to WT rats.
In vitro DTI analysis and histology confirms WM damage in rTg-DI CAA type 1 rats 
Whole brain DTI image analyses focused on analyzing the key DTI index FA within the WM 
tissue compartment and FA values within the age groups for WT and rTg-DI rats are summarized 
in Supplementary Table 2. This analysis revealed that the mean FA was found to be significantly 
different at 9M and 11M of rTg-DI compared to age-matched WT. The voxel-wise FA analysis 
was performed at the four age groups separately, minor areas of significant differences between 
the two groups were observed at 9M (results not shown). At 11M widespread areas with significant 
group differences were found as shown in Figure 3. Largely consistent with the pattern of WM 
loss observed in vivo as shown in Figure 2, the rTg-DI rats displayed significantly reduced FA 
values (indicating impaired WM integrity) in several WM structures including CC, AC, fornix, 
internal capsule, reticular thalamic nuclei and deep mesencephalon. We also observed small focal 
areas with higher FA values in rTg-DI compared to WT rats (Figure 3). These focal FA increases 
in rTg-DI rats occurred near the ventral posteromedial thalamic nuclei (VPM) and gustatory 
thalamic nuclei suggesting enhanced anisotropy in these specific areas. 
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To evaluate topographical patterns of reduced FA within WM tracks including the CC, AC 
and the projection fibers from CC to FC between the two strains at 11M, we extracted and plotted 
their respective FA values along planes orthogonal to the long axis of the ROIs (Supplementary 
Figure 6). In normal WT rats, the FC projection fibers exhibited a monotonically decreasing trend 
as the slices became closer to the cortex (Supplementary Figure 6). Similarly, in normal WT rats, 
FA values within the AC, became lower as the slices approached the olfactory bulb. When 
comparing across strains, differences in FA values were noted to be slice dependent. For example, 
in the CC, substantial FA decreases (~15 %) in rTg-DI rats were found in the body of CC compared 
to WT rats, while FA values in the genu and splenium were within similar range (~2 %) for the 
two strains. In the AC, the anterior portion exhibited larger differences (~10 % lower in rTg-DI 
rats) compared to the posterior portion (~3 % lower in rTg-DI rats). In contrast, FC slice profiles 
were nearly identical across all slices except first several slices, which were positioned proximal 
to the body of CC which exhibited relatively high FA values (~0.4). In summary, the topographical 
analysis of FA changes in the pre-selected WM tracks showed that in rTg-DI rats, large portions 
of the CC body and the AC displayed WM loss while the genu of the CC and the FC were less 
effected. 
Myelin staining in brain sections from a parallel group of aged WT and rTg-DI rats 
revealed an obvious thinning and significant ~30 % reduction (p-value < 0.05) in the volume of 
the CC (Figure 4A-C). Similarly, quantitative measures showed a significant >40 % reduction (p-
value < 0.01) in myelin basic protein (MBP) levels in the CC of these rats further supporting the 
reduction in WM in this region (Figure 4D). Together, these pathological findings are highly 
consistent with WM loss observed in the MR imaging (Figures 1, 2 and 3). Supplementary Figure 
7 presents immunohistochemical labeling of axons with the pan-axonal neurofilament marker 
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SM312 to further validate the MRI and histopathology data by documenting differences in normal 
and pathological axons in several WM regions in 11M WT and rTg-DI rats. Guided by the MRI 
results of WM damage we focused on documenting axonal pathology in the CC (body and genu) 
and thalamus. At 11M of age obvious strain differences were noted between WT and rTg-DI rats 
(Supplementary Figure 7B-I). First, thinning of the CC above the dorsal hippocampus in the 11M 
rTg-DI rats compared to WT was clearly discernable (Supplementary Figure 7B, F). Second, in 
11M rTg-DI rats, general axonal loss was evident throughout the body of the CC compared to 11M 
WT (Supplementary Figure 7C, G). Also, in the genu of the CC, axonal density did not appear to 
be affected, however, general disintegration (i.e. shorter axonal segments and lack of axonal 
coherence) was noted in the in rTg-DI rats compared to WT rats (Supplementary Figure 7D, H). 
Finally, in the thalamus, axonal density was reduced, and axonal directional pattern appeared 
disrupted in the 11M in rTg-DI rats when compared to WT (Supplementary Figure 7E, I). 
Thalamic and cortical T2* hypointensities emerge at 6M in rTg-DI rats 
T2* maps of the brain reflect local magnetic susceptibility and are therefore sensitive for detecting 
blood products and other macro- or microscopic inhomogeneities within a given tissue 
compartment.59-61 We used T2* maps primarily for detecting evolution of thalamic CMB in the 
rTg-DI rats over time. Color-coded T2* maps as shown in Figure 5A anatomically distinguish 
WM regions (e.g. CC, fimbria, internal capsule and cerebellar WM) from GM regions due to 
myelin’s inherently lower transverse relaxation time (WM T2* ~25 ms, green colors). Second, 
when comparing T2* brain maps of WT to rTg-DI rats, the most striking abnormalities are the 
bilateral, symmetrical thalamic T2* hypo-intensities. Third, areas in cortex also exhibited reduced 
T2* differences between the two strains. Specifically, column-shaped hypointensities began to 
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manifest at 6M in rTg-DI rats and became progressively more prominent with aging but were 
mostly absent in WT rats (Supplementary Figure 8). The column-shaped T2* hypo-intensities 
penetrated the entire cortex and appeared to merge with CC. Voxel-wise T2* analyses were 
performed to identify areas with statistically significant age-dependent T2* differences between 
WT and rTg-DI rats. Figure 5B shows the statistical parametric maps at 3M, 6M, 9M and 11M of 
significantly reduced T2* values in rTg-DI compared to WT rats (with color-coded p-values) 
overlaid onto a population averaged anatomical PDW template. At 3M no differences were found 
in T2* between the two strains. However, at 6M significantly reduced T2* values were observed 
within the ventral posterolateral (VPL) and ventral posteromedial (VPM) nuclei and these thalamic 
areas grew in size at 9M and 11M to encompass the entire thalamus. Thalamic, focal hypointense 
lesions were apparent on T2* in 100% of the rTg-DI rats at 11M of age. In rTg-DI but not WT 
rats, significant widespread T2* reductions in the cortices were also evident at 9M and 11M 
(Figure 5). Figure 6 shows the age-dependent trajectories of (1) total thalamic CMB load in rTg-
DI rats from 3M to 11M as evaluated by T2* values (Figure 6A), (2) age-dependent CMB volume 
growth derived from calculating voxels with T2* values ≤ 20ms within the thalamus (Figure 6B) 
in comparison to WT rats. In agreement with voxel-wise analysis statistical analysis of age-
dependent CMB load trajectories from the two strains based on T2* shows that their profiles 
(curves) are different across the age groups (p-value < 0.0001, Figure 6, Supplementary Table 3). 
Specifically, based on T2* data CMB starts emerging at 6M in rTg-DI rats (Figure 6A). Based on 
volumetric assessment CMB emerge at 6M and at 11M CMB volume in rTg-DI rats averaged ∼7 
mm3. Of note, the T2* threshold of ≤ 20ms for quantifying CMB was set empirically based on 
‘best match’ of the focal hypo-intense lesions observed bilaterally in thalamus, and very small 
CMB might not be captured by this approach.
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We also confirmed the presence of thalamic CMB in all rTg-DI rats at 11M as defined by 
Prussian blue iron staining for perivascular hemosiderin deposits (Figure 6F). In the longitudinal 
cohort of rTg-DI rats, CMB were observed within the VPM/VPL thalamic nuclei bilaterally 
(Figure 6C-G). In all rTg-DI rats petechial Prussian blue positive deposits were observed to be 
diffusely dispersed in the thalamus and in the majority of rTg-DI rats numerous occluded and 
calcified microvessels were also evident (Figure 6F, G). Prussian blue positive ferritin products 
were not observed in the cortex (not shown) including areas associated with the column-shaped 
hypointense signal on the T2* maps (Supplementary Figure 8). In a subset of 11M old rTg-DI rats 
the % area fraction of hemosiderin was measured in the thalamus revealing 2.01 ± 0.70% (n = 4; 
SD) for hemosiderin coverage in this region, consistent with previous findings.40
Given the clinical literature associating vascular amyloid deposition with CMB and the 
Boston criteria for CAA diagnosis62, 63 we also investigated amyloid deposition patterns in 11M 
old rTg-DI rats in pre-selected areas (Figure 7). Perivascular capillary Aβ deposits in rTg-DI rats, 
were abundant in cortex, hippocampus and thalamus (Figure 7C-E). Further, the microvascular Aβ 
deposits were strikingly dense in the thalamic region (Figure 7E) when compared to the cortex and 
hippocampus (Figures 7C, D). Further, quantification of the % area capillary amyloid coverage 
confirmed the high level of perivascular capillary Aβ deposits in thalamus (Figure 7F). Thus, the 
emergence of CMB in the thalamic region is likely associated with the heavy microvascular Aβ 
burden in this region. As expected, perivascular neuroinflammation in form of astrogliosis and 
activated microglia in rTg-DI rats was also pervasive in 11M rTg-DI rats in regions with heavy 
microvascular amyloid burden such as the thalamus and hippocampus in comparison to WT 
(Supplementary Figure 9). Astrocytes appeared to be increased in number and volume in 11M rTg-
DI rats (Supplementary Figure 9E-H) when compared to 11M WT rats (Supplementary Figure 9A-
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D). In the hippocampus and thalamus of WT rats Iba 1-positive microglia were sparse in numbers 
and exhibited the resting, surveillance phenotype with long extended processes (Supplementary 
Figure 9K, L). In contrast, in 11M rTg-DI rats the number of microglia in hippocampus and 
thalamus was increased and the microglia phenotype was activated with the characteristic enlarged 
cell bodies and retracted processes (Supplementary Figure 9O, P). 
Discussion
The contribution of CAA pathology to subcortical WM disease is a critical question to 
address for understanding the role of CAA in the pathogenesis of VCID and AD.64-66 The overlap 
of clinical symptoms between AD nd CAA poses significant challenges for understanding their 
respective contributions to VCID and ultimately for advancing preventive and novel therapeutics. 
Here we used our novel rTg-DI transgenic rat model of the CAA-type 140 in combination with 
advanced MRI and histological measures to show that evolving CAA type 1 pathology, including 
CMB, is associated with WM disease. The demonstrated reliability of MRI measures of WM 
disease with aging makes in vivo MRI studies of the rTg-DI rat model ideal for studying CAA type 
1 in isolation without other comorbidities like hypertension or other AD pathologies. Further, the 
4-fold larger brain size in comparison with the mouse brain allows improved anatomical resolution 
using in vivo MRI. 
To execute the longitudinal in vivo MRI study, we combined two time-efficient sequences 
designed to track morphometry as well as CMB. We used a PDW sequence for WM and GM 
morphometric analysis similar to our previous study on spontaneously hypertensive rats44 and for 
CMB load we implemented a multiple gradient echo sequence to derive T2* maps allowing for 
quantitative age-dependent comparisons across animals and groups. We further validated WM loss 
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by implementing in vitro DTI on separate series of rTg-DI and WT rats to assess WM integrity via 
FA analysis. The morphometric quantitative in vivo data showed that rTg-DI rats (but not WT 
controls) started developing WM loss in the CC at 6M, which rapidly progressed at 9M and 11M 
into a specific pattern of WM loss incorporating the entire body of the CC, internal capsule, AC, 
thalamus and midbrain. The WM loss documented in vivo was confirmed by in vitro DTI and 
histology. Remarkably, in spite of massive perivascular Aβ deposition and neuroinflammation in 
cortex, hippocampus and thalamus the rTg-DI rats did not exhibit more significant age-dependent 
GM loss when compared to WT controls at any time point. We also demonstrated that CMB 
emerged at 6M in the thalamus in rTg-DI rats and dramatically expanded in thalamus at 9M and 
11M. The total thalamic CMB volume was not strongly associated with total WM loss in rTg-DI 
rats (results not shown). 
Cerebral microbleeds (CMB) in CAA type 1 rTg-DI rats
According to the Boston criteria, the key diagnostic imaging features related to a probable case 
of CAA pathology in humans, is the presence of cerebral micro/macrohemorrhages.28, 62 CAA 
related hemorrhage is thought to result from excessive vascular Aβ deposits leading to 
structurally brittle vessels that are unable to withstand changes in blood pressure.67 An alternate 
hypothesis states that increased expression of proteolytic enzymes contributes to CMB by 
disrupting the vessel wall in CAA.25 In support of clinical data linking CAA pathology with 
cerebral hemorrhage, in the rTg-DI rats CMB emerged in the thalamus which also exhibited the 
most extensive deposition of microvascular fibrillar Aβ. A dense network of capillaries with 
microvascular amyloid was evident in thalamus when compared to cortex and hippocampus. 
Other reasons for the susceptibility of the thalamus to microvascular Aβ deposition and CMB 
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should be noted. In rodents the thalamus is proportionately larger than other brain regions 
compared with the proportions in the human brain. Therefore, it seems more plausible that 
perivascular Aβ accumulation including microbleeds will emerge in the rodent in the thalamus. 
Another possibility for extensive perivascular Aβ accumulation in the thalamus may be related to 
patterns of glymphatic transport flow and waste drainage which has been shown to be less 
efficient in deep regions such as the thalamus.68-70
In the rTg-DI rats, CMB as defined by lower T2* values was observed to emerge at 6M in 
the ventral posteromedial and posterolateral thalamic nuclei. CAA type 1 (as documented in this 
study) is not the only cSVD associated with thalamic CMB. In patients with genetic forms of 
CADASIL ~50 % have microbleeds and these are mostly in the deep structures including 
thalamus.71, 72 In clinical cases of sporadic cSVD the pattern and prevalence of CMB varies with 
the underlying type of cerebral angiopathy, its severity and age of patient, but in general up to 
about 20 % of patients with sporadic cSVD have a CMB somewhere.73 The Boston criteria state 
that microbleeds at the cortical grey-white matter junction (so-called lobar microbleeds) indicate 
CAA whereas those in deep structures like thalamus, internal capsule, lentiform and caudate nuclei 
indicate hypertensive small vessel pathology. However, in human CAA, although there are often 
many lobar microbleeds, there are often microbleeds in the deep structures including thalamus 
(personal observation, Dr. Wardlaw). Of note, CMB are also observed in the thalamus in 
preference to other sites in other rodent cSVD models for example the carotid coil hypoperfusion 
models74 and in the APP23 mouse model.75 
We observed column-shaped T2* hypo-intensities in the somatosensory cortex of rTg-DI 
rats which were not associated with histological evidence of hemorrhage and therefore must be 
attributed to alternate pathophysiology. Quantitative T2* maps reflect local magnetic 
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susceptibility within a given tissue compartment which can be affected by a variety of physical 
and physiological effects including iron deposition, deoxyhemoglobin, low tissue oxygenation 
levels, high myelin content, vessel dilation, capillary tortuosity, and/or dense core parenchymal 
Aβ plaques.60, 76-78 As we excluded iron deposition by histology and the absence of dense core Aβ 
plaques in the rTg-DI rats, alternative explanations should be explored. The cortical column-
shaped T2* hypo-intensities could signify vascular remodeling/dilation related to the CAA type 1 
pathology.40, 79 Given that most of the column-shaped hypo-intensities appeared in somatosensory 
cortex including barrel cortex it is reasonable to suggest that they might represent diaschisis of 
cortical functional column/units in form of secondary damage due to the thalamic CAA and CMB 
involving VPM and VPL.80 In this context it is noteworthy that rTg-DI mice and rats display early 
signs of deficit in the novel exploration behavioral tasks.40, 55 In this particular test the rodents are 
placed in an open field to explore for novel and distinct objects of a short trial period, and the rTg-
DI rats exhibit slowing in the manner of exploration of the unique objects suggesting perceptual 
slowing.40 This behavioral phenotype could be explained by the lack of major input they would 
use in exploring new environment and stimuli (e.g. projections from the thalamic VPM to barrel 
cortex).
Diffuse white matter loss in rTg-DI rats
WM degeneration detected by VBM and DTI analyses was robustly observed in rTg-DI 
rats around 9M of age and included CC, internal capsule, AC, thalamus and midbrain. 
Topographical WM differences between the two strains detected by the morphometric VBM 
analysis based on PDW images and FA based DTI maps were noted. Both modalities consistently 
yielded WM compromise in CC, AC, certain parts of thalamus and midbrain (Figure 2 and Figure 
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3) in rTg-DI compared to WT rats. The loss of WM in the CC observed by imaging was supported 
by histological myelin staining as well as by direct measurement of MBP levels in the CC 
supporting the overall analysis and conclusions. However, the extent of WM damage in thalamus 
and midbrain was different which is likely due to the different parametric measure. The FA 
parameter is sensitive to loss of WM integrity in pure WM areas and thalamus, the latter of which 
is a mix of WM and GM, which is therefore an area with inherently lower FA values in normal 
brain. On the other hand, the VBM analysis based on PDW contrast includes the entire thalamus 
in the WM template, was more sensitive to WM loss and detected difference at 9M as well as 11M. 
In addition axonal loss and disruption of WM tracts including the CC and thalamus was confirmed 
by the SM312 pan axonal neurofilament marker (Supplementary Figure 7). The progressive WM 
loss and CMB load in thalamus in the rTg-DI rats affect their cognitive function. In the recent 
study by Popescu and colleagues, a comprehensive age-dependent analysis of cognitive function 
and behavior in the rTg-DI and WT rats was described using a battery of behavioral tasks.81 In this 
study WT and rTg-DI rats were first evaluated at 3M of age and habituated to operant training; 
with data collection beginning at 6M (when microvascular amyloid starts becoming more 
extensive) and continuing for 4M until a final evaluation at 12M when microvascular Aβ is severe 
and WM loss significant.81 The behavioral task performance analysis revealed a general ‘slowing’ 
of cognition (rather than deficient memory capacity) starting at 7M in the rTg-DI rats which 
progressively worsened.81 Specifically, cognitive assessments showed that rTg-DI rats interacted 
with their environment more hesitantly and perform ‘slower’ when compared to WT rats consistent 
with thalamo-cortical dysfunction impacting sensorimotor integration.
We explored the possible mechanisms which might underlie WM loss in the rTg-DI rats. 
First, WM structures in the rTg-DI rats such as the CC and AC exhibited neither CMB, excessive 
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Aβ deposition nor neuroinflammation indicating that axonal damage was not directly related to 
either of these pathologies in contrast to what was recently reported in a mouse model of pericyte 
degeneration.82 The temporal trajectory of CMB and WM damage suggested that WM damage 
succeed the thalamic CMB. However, statistical analysis did not support strong association 
between thalamic CMB and WM loss which might be attributed to a small sample size combined 
with a noisy CMB readout signal from the T2* maps. Future studies will need to further explore a 
potential association between these two parameters. Regardless, the anatomical specificity of WM 
loss in the CC, AC and midbrain suggest that it is either secondary (or Wallerian) to the thalamic 
CMB similar to what is reported in CADASIL patients.71, 72, 83
In summary, white-matter hyperintensities is a well establish imaging feature of normal 
aging in human and its burden is also associated with cSVD and CAA.8, 84 However, until now it 
has been unclear if CAA pathology alone may contribute to WM degeneration since clinical cases 
of CAA most often overlap with other cSVD subtypes or AD. Our study now provides novel 
evidence that CAA type 1 pathology can lead to significant WM loss and degeneration and the 
extent of WM loss is likely to underly the early behavioral deficits observed in rTg-DI rats. The 
evidence of WM loss in CAA is important because long range cortical projection fibers are of great 
interest in understanding VCID in cSVD.10, 85, 86 The present findings further underscore the utility 
of rTg-DI rats to further explore the mechanistic basis of WM degeneration in CAA.
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Titles and legends to figures
Figure 1: Significantly greater white matter loss observed in rTg-DI compared to WT rats 
Mean and 95 % confidence bands for age-dependent volumetric changes of the grey matter (GM) 
(A), white matter (WM) (B) for WT (blue, filled circles) and rTg-DI rats (red, filled circles) 
extracted from proton-weighted magnetic resonance images acquired in vivo. Observations for the 
WT group have been shifted slightly left of the rTg-DI group at each age to more clearly display 
the data. Individual filled circles represent individual rats. Model estimates are presented as means 
(filled squares) with 95% pairwise confidence intervals (black bands) using Generalized 
Estimating Equations (GEE). Mean differences were tested for rTg-DI vs WT groups at each age 
group. For the GM compartment, the results revealed no significant volumetric differences 
between strains tested at each age. For WM volume, the mean profiles between rTg-DI and WT 
rats differed statistically across the age groups (p-value < 0.001).
Figure 2: Age-dependent WM loss occurs in a specific anatomical pattern in rTg-DI rats
(A) Spatially normalized population averaged WM volumetric maps of 11 month (M) old rTg-DI 
and WT rats are shown in color maps, highlighting extensive WM loss in 11M rTg-DI rats 
compared to WT. (B) For each age group, statistical parametric maps (color coded for p-values) 
were calculated at p-value < 0.05 after FDR multiple comparison correction and overlaid onto 
population averaged proton density weighted MRI images to display anatomical areas with 
significant white matter (WM) loss in rTg-DI in comparison to WT rats. Cohen’s d represents the 
effect size. Anatomical levels of the axially displayed anatomical templates are given by their 
nearest Bregma distance. At 3M and 6M only the corpus callosum (CC) and deep mesencephalic 
nuclei (DpMe) were significant for WM loss in the rTg-DI rats. However, at 9M and 11M, 
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significant WM loss in rTg-DI rats was widespread and included the CC, globus pallidus (GP), 
internal capsule (IC), thalamus and central tegmental tract (ctg). Scale bar = 15 mm.
Figure 3: WM loss in rTg-DI rats with late stage disease validated by in vitro DTI
A: Anatomical templates based on FA contrast are shown to highlight landmarks. Anatomical 
landmarks of the templates are indicated by their nearest Bregma distance. Anatomical structures 
of relevance are as follows: CC = Corpus Callosum; LS = Lateral Septum; AC = Anterior 
Commissure; Cpu = Caudate Putamen; IC = Internal Capsule; f = fornix; mt = mammillothalamic 
tract; VPM = Ventral posteromedial thalamic nuclei; Rt = reticular thalamic nuclei; DpMe = Deep 
mesencephalic nuclei; SNR = Substantia Nigra; VTA = Ventral Tegmental Area; Hip = 
Hippocampus; ctg = central tegmental area. B: Brain areas where FA values are significantly 
different (color coded for p-values) in 11M old rTg-DI rats compared to the age-matched WT rats 
are shown. Cohen’s d represents the effect size. Scale bar = 15 mm.
Figure 4: Myelin loss in the corpus callosum of rTg-DI rats
Representative sagittal sections from 11 M old WT rat (A) and rTg-DI rat (B) stained for myelin 
showing a reduction in the size of the corpus callosum. Scale bars = 1000 µm. (C) Stereological 
quantitation of the corpus callosum volume from 11 M WT (black dots) and rTg-DI (red dots) rats. 
Data shown are the mean ± SD of n =3 rats per group; p-value < 0.05. (D) The corpus callosum in 
11 M WT and rTg-DI rats was collected by laser capture microscopy and MBP levels were 
determined by quantitative immunoblotting. Data shown are the mean ± SD of n = 3 rats per group; 
p-value < 0.01.
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Figure 5: Brain areas with reduced T2* values in rTg-DI compared to WT rats
A: Spatially normalized population averaged color-coded T2* maps of 11M old rTg-DI and WT 
rats. Blue and red colors represent low and high T2* values, respectively. Significantly reduced 
T2* values (white arrows) in the thalamus is suggestive of blood products. B: Voxel-wise T2* 
analyses were performed to quantify areas with statistically significant T2* differences between 
WT and rTg-DI rats at 3M, 6M, 9M and 11M of age. The statistical parametric maps of 
significantly reduced T2* values in rTg-DI rats compared to WT rats (with color-coded p-values) 
are overlaid onto a population averaged anatomical PDW template and shows changes in thalamus 
(ventral posteromedial nucleus (VPM)), subiculum (subic), and in the somatosensory cortices. 
Cohen’s d represents the effect size. Scale bar = 15 mm.
Figure 6: Thalamic microbleeds by T2* emerge at 6M in rTg-DI rats
A: Age-dependent trajectories of the total thalamic CMB load in rTg-DI rats from 3M to 11M as 
evaluated by mean T2* values. Blue and red filled circles represent WT and rTg-DI rats, 
respectively. Statistical analyses show that age-dependent trajectories of the two strain are 
statistically different with respect to the age groups (p-value < 0.0001). A distinct difference 
between mean T2* data is present at 6M in rTg-DI rats: mean T2* is 1.8 ms lower than WT rats, 
(p-value = 0.001). B: Age-dependent CMB volume derived based on number of voxels with T2* 
values ≤ 20 ms within the thalamus in comparison to WT rats. Blue and red filled circles represent 
WT and rTg-DI rats, respectively. Rapid CMB growth is apparent at 9M and onwards in rTg-DI 
rats (p-values for pairwise mean differences at both 9M and 12M < 0.001). Model estimates are 
presented as means (filled squares) with 95 % pairwise confidence intervals (black bands) using 
Generalized Estimating Equations (GEE). C: Anatomical proton-density weighted MRI from a 
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rTg-DI rat in the sagittal plane at the level of the dorsal hippocampus and thalamus. Thal = 
thalamus. D: Corresponding T2* map from the same rat shown in (C). The hypointense areas in 
the Thal are evident. E: Post-mortem histological stain for perivascular hemosiderin using Perl’s 
Prussian Blue stain. The black box depicts the magnified areas (F, G). F: Magnified area from the 
thalamus showing numerous small deposits hemosiderin deposits (indicated by blue arrows), many 
surrounding what appear to be occluded vessels. G: Numerous occluded and calcified microvessels 
were confirmed in the same thalamic area. Scale bars = 50 µm. 
Figure 7: Pattern of microvascular fibrillar Aβ deposition in 11M rTg-DI rats
A: Sagittal plane from a proton-density weighted MRI of a WT rat highlighting anatomical areas 
of interest: Cortex (Ctx), hippocampus (Hip) and thalamus (Thal). B: Sagittal brain section from a 
11M old rTg-DI immunolabeled with thioflavin S (ThS) to identify fibrillar amyloid (green). The 
white boxes highlight the anatomical areas magnified in C-E which are sections from these areas 
now immunolabeled with rabbit polyclonal antibody to collagen IV to specifically detect cerebral 
microvessels (red) and stained with ThS to identify fibrillar amyloid (green). The microvascular 
amyloid deposits are clearly present in Ctx (C), in the hilus region of the hippocampus (D) and in 
the thalamus (E). Scale bars = 50 µm. (F) The quantitation of microvascular amyloid load in the 
three brain regions confirming the thalamic area is most heavily affected.
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Abstract
Diffuse white matter (WM) disease is highly prevalent in elderly with cerebral small vessel disease 
(cSVD). In humans, cSVD such as cerebral amyloid angiopathy (CAA) often coexist with 
Alzheimer’s disease imposing a significant impediment for characterizing their distinct effects on 
WM. Here we studied the burden of age-related CAA pathology on WM disease in a novel 
transgenic rat model of CAA type 1 (rTg-DI). A cohort of rTg-DI and wild type rats was scanned 
longitudinally using MRI for characterization of morphometry, cerebral microbleeds (CMB) and 
WM integrity. In rTg-DI rats a distinct pattern of WM loss was observed at 9M and 11M. MRI 
also revealed manifestation of small CMB in thalamus at 6M, which preceded WM loss and 
progressively enlarged until the moribund disease stage. Histology revealed myelin loss in the 
corpus callosum and thalamic CMB in all rTg-DI rats, the latter of which manifested in close 
proximity to occluded and calcified microvessels. The quantitation of CAA load in rTg-DI rats 
revealed that the most extensive microvascular Aβ deposition occurred in the thalamus. For the 
first time using in vivo MRI, we show that CAA type 1 pathology alone is associated with a distinct 
pattern of WM loss. 
Key words: Cerebral amyloid angiopathy; transgenic rat; microbleed, DTI, white matter
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Introduction
Compelling clinical evidence implicates a major role of cerebral small vessel disease (cSVD) in 
vascular cognitive impairment and dementia (VCID).1 cSVD are disorders caused by pathologies 
of the small blood vessels in the brain.2-5 cSVD contributes to and worsens Alzheimer’s disease 
(AD) symptoms6 and triples the risk of stroke.7, 8 The underlying pathogenesis of cSVD is still 
poorly understood and no effective preventive or curative treatments currently exist.9 cSVD are 
diagnosed by distinct pathologies detected by magnetic resonance imaging (MRI) including white 
matter (WM) hyperintensities, diffuse WM loss, enlarged perivascular spaces (ePVS), lacunar 
infarcts, cerebral microbleeds (CMB), microinfarcts and global brain atrophy.5, 10-13 
Several different subtypes of cSVD that often overlap in human brain are observed based 
on the cerebral vessel bed impacted.14 The most common cSVD subtypes are arteriolosclerosis, 
cerebral small vascular atherosclerosis and cerebral amyloid angiopathies.4, 15-17 Sporadic cerebral 
amyloid angiopathy (CAA) is the second most common cSVD subtype in the elderly and is 
characterized by the presence of fibrillar amyloid-beta protein (Aβ) deposits in the vessel walls of 
meninges, cerebral arteries, arterioles and capillaries. The age-related prevalence rates of CAA are 
>50% over 80 years.15, 18, 19 CAA manifests as two distinct pathologies designated as CAA type 1 
and CAA type 2.20 CAA type 1 is characterized by the Aβ deposition in the capillaries causing 
dyshoric angiopathy and a strong neuroinflammatory response.21-23 In contrast, CAA type 2 is 
characterized by Aβ deposition within the vessel walls of cortical and meningeal arteries and 
arterioles.24 The extensive and chronic vascular Aβ deposition in late-stage CAA is associated with 
CMB, larger lobar hemorrhages or focal ischemic insults.23, 25-27 
Presently, the Boston criteria provides a ‘probable’ diagnosis of CAA based on the 
demonstration of multiple hemorrhages restricted to lobar, cortical or cortical-subcortical regions 
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by imaging.28-30 Although the two different CAA subtypes are well-recognized in post-mortem 
human brain20 their contribution to diffuse WM disease is unknown because they commonly co-
exist with AD and cannot be studied in isolation.31-36 Thus, despite the high prevalence of WM 
disease in cSVD and its significance for VCID there is a gap in knowledge regarding its 
progression over time and how it relates to burden of CAA pathology including CMB.
Transgenic mouse cSVD models that develop CAA type 1 or CAA type 2 without other 
overlapping cSVD pathologies (e.g. hypertensive vasculopathies or AD)24, 37-40 have provided 
valuable insights into understanding how cerebral vascular amyloid, CMB and other 
pathophysiology relate to cognitive dysfunction as the disease progresses. However, thus far 
diffuse WM disease has not been reported in CAA mouse models which brings into question their 
relevance for human cSVD. Recently we introduced a novel CAA transgenic rat model that 
expresses chimeric Dutch/Iowa familial CAA mutant Aβ in brain (rTg-DI) and develops age-
dependent deposition of capillary Aβ, perivascular neuroinflammation, CMB and behavioral 
deficits.40 The new rTg-DI rat model now allows further investigation into how the evolving CAA 
type 1 pathology impacts WM in the live brain by MRI. In this study, the evolution of CMB and 
brain morphometry were characterized longitudinally in a cohort of rTg-DI rats from early stage 
disease at 3-month (M) of age until rTg-DI became moribund (~11M). The in vivo MRI findings 
were validated by in vitro 3D diffusion tensor imaging (DTI) as well as histological measures of 
WM loss, CAA load and CMB. The ultimate goal of these experiments is to inform on the burden 
of age-related CAA type 1 pathology in relation to WM disease and ultimately to future efforts 
addressing VCID in CAA.
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Material and Methods
Animal, strains and genotyping
All animal experiments were approved by the Institutional Animal Care and Use Committees at 
Yale University and University of Rhode Island and conducted in accordance with the United 
States Public Health Service’s Policy on Humane Care and Use of Laboratory Animals and the 
experiments have been reported in compliance with the ARRIVE guidelines. The rTg-DI CAA 
type 1 rat line expresses human Swedish/Dutch/Iowa vasculotropic mutant amyloid-beta precursor 
protein (AβPP) under control of the neuronal Thy1.2 promoter and produces chimeric Dutch/Iowa 
CAA mutant Aβ peptides in brain.40 Heterozygous transgenic offspring of rTg-DI rats were used, 
and all transgenic rats were confirmed for the human AβPP transgene by genotyping. In vivo MRI 
experiments were conducted longitudinally on the same cohorts of WT and rTg-DI female rats at 
3M, 6M, 9M, and until they were severely impacted by CAA type 1 disease and became moribund 
(as evidenced by rapid >10-20% weight loss compared to control loss which occurred ∼11M of 
age in rTg-DI rats). In addition, we also included separate groups of female and male rTg-DI and 
WT rats ranging from 3-11M for in vitro WM characterization by DTI. All MRI acquisitions were 
performed on a Bruker 9.4T/16cm bore MRI instrument with a BGA-9S-HP imaging gradient 
interfaced to a Bruker Avance III console and controlled by Paravision 6.1 software (Bruker Bio 
Spin, Billerica, MA, USA). A volume RF transmit and receive head only coil with an inner 
diameter of 4.0 cm was utilized for both in vivo and in vitro MRI scans. During the scans anesthesia 
was maintained with dexmedetomidine (0.015-0.020 mg/kg/hr via a subcutaneous catheter) 
supplemented with 0.5-0.8 % isoflurane delivered in a 1:1 Air:O2 mixture.41 The stability of 
anesthetic plane was assessed by means of continuous measurement of heat rate and blood oxygen 
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saturation (SpO2) during the scanning. SpO2 was kept in the range of 97-100% during scanning. 
Body temperature was kept in the range of 36-37oC using a heated waterbed.
In vivo MRI sequences 
For morphometric scans a proton-density weighted (PDW) 3D spoiled gradient echo sequence was 
used with the following parameters: Repetition time (TR) = 50 ms; echo time (TE) = 4 ms; flip 
angle = 7o; number of signal averages (NA) = 4, total scan time = 27 min. A saturation pulse was 
applied ventral to the lower jaw to prevent image aliasing artifact within the field of view (30 mm 
x 30 mm x 15 mm) allowing for an isotropic spatial resolution of 0.23 mm x 0.23 mm x 0.23 mm. 
Following the PDW scan, a 3D multiple gradient echo (MGE) sequence (T2*-weighted) was 
acquired for CMB detection with the same spatial resolution (0.23 mm x 0.23 mm x 0.23 mm) and 
orientation  as the PDW image using following parameters: TR =  60 ms; TE = 2 ms,12 ms, 22 ms, 
32 ms; flip angle = 15; NA = 6 yielding a total scanning time of 49 min. 
In vitro DTI imaging
The signal intensity on PDW images varies across the brain, which facilitates the anatomical 
segmentation into three tissue compartments: GM, WM and cerebrospinal fluid (CSF). In the 
setting of pathological changes (e.g. CMB or tissue degeneration) erroneous tissue segmentation 
based on anatomical image contrast could in principle occur. Therefore, to further validate the 
morphometry-based assessment of WM changes we also implemented DTI imaging in separate 
series of rats. Accordingly, in vitro MRI scans were performed on an additional series of WT and 
rTg-DI rats at 3M, 6M, 8M, and 11 M using the active gadolinium staining technique.42, 43 
Following an overdose of ketamine (~130mg/kg) rats underwent transcardial perfusion fixation 
with a mixture of phosphate buffer 4% paraformaldehyde solution (SF-100 Fischer Scientific) 
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containing 5% (50 mM) Gadoteric acid (Gd-DOTA Guerbet LLC, Princeton, NJ, USA) delivered 
by a servo-controlled peristaltic pump (Masterflex Peristaltic Tubing Pumps, Cole-Parmer, Vernon 
Hills, IL, USA). Prior to imaging, the specimens were allowed to reach a room temperature (19-
21oC) before being placed in a custom-made MRI-compatible holder containing proton signal-free 
susceptibility matched fluid (Galden Heat Transfer Fluids, HT230. Kurt J. Lesker, Company, 
USA). A 3D pulsed gradient spin-echo DTI imaging protocol was implemented using following 
parameters: TR = 350 ms; TE = 20 ms; NA = 1; diffusion time = 4 ms; gradient duration = 10 ms; 
isotropic voxel resolution of 156 µm x 156 µm x 156 µm. One non-diffusion weighted image (b = 
20 s/mm2) image and 6 diffusion weighted images (b = 2500 s/mm2) were acquired along 6 non-
collinear diffusion gradient vectors: [1, 1, 0], [1, 0, 1], [0, 1, 1], [-1, 1, 0], [1, 0, -1], and [0, -1, 1] 
requiring a total acquisition time of 11 h 9 min per specimen. 
In vivo MR imaging analyses
Analyses of in vivo MRI data included characterizing morphometric and T2* differences between 
rTg-DI and WT rats at the four time points (3M, 6M, 9M and 11M). PDW image analysis: The 
PDW images were used for voxel-based morphometry (VBM) to characterize the age-dependent 
morphometric voxel-wise differences between rTg-DI and WT groups. For this purpose, image 
registration and subsequent voxel-wise statistical analyses were performed using SPM12 
(http://www.fil.ion.ucl.ac.uk/spm) as previously described44-46 using custom-made GM, WM and 
CSF tissue probability maps (TPMs) (Supplementary Figure 1).44, 47, 48 Spatial registration 
parameters between TPMs and individual scans were calculated using the DARTEL algorithm and 
subsequently smoothed by a 0.6 mm Gaussian smoothing kernel. Voxel-wise statistical analysis 
was performed by a two-sample t-test with total intracranial volume (TIV) as a covariate and 
statistical significance was reported at p-value<0.05 after correcting for multiple comparison by 
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false discovery rate (FDR). T2* analysis: A relationship between a MGE signal as a function of 
echo time is complex and studies have reported non-mono exponential decay49, which require data 
collection over many TEs. In this study we instead implemented the commonly performed mono-
exponential decay as the first approximation. Thus, the 3D T2* maps were calculated from the 
MGE data by assuming mono-exponential signal decay between the detected signals and the echo 
times. The signals were log transformed and fitted as a function of the echo times using a linear 
least square fit algorithm. To spatially register the T2* maps onto the anatomical PDW templates 
the spatial transformation parameters estimated for the VBM analysis was used. Following this 
processing step, the T2* map was smoothed with an isotropic Gaussian kernel of 0.6 mm. A two-
sample t-test was performed and voxel-wise differences for T2* was considered statistically 
significant at p-value < 0.05 after correcting for multiple comparison by FDR. For both VBM and 
T2* map images, the voxel-wise analyses were executed separately, at each scan point (3M, 6M, 
9M and 11M). The T2* maps were also used for estimating the trajectory of CMB ‘load’ and 
volume changes in the thalamus over time in rTg-DI rats compared to WT rats. For this purpose, 
a thalamic ROI was overlaid onto the T2* maps and the mean T2* value was extracted for each 
rat at each scan time point. T2* values ≤ 20 ms within the thalamus was identified on the parametric 
T2* maps in each rat using the Amira software segmentation editor (Amira 6.4, ThermoFisher 
Scientific). The setting of the T2* threshold of ≤ 20ms to quantify the thalamic CMB were 
determined based on two experienced imagers’ (HB and HL) assessment of ‘best match’ with the 
well-defined low intensity regions observed bilaterally in the thalamus. The number of voxels with 
T2* ≤ 20 ms was converted into mm3 and used as an estimate of ‘total hemorrhagic load’ in the 
thalamus. 
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In vitro DTI imaging analyses: 
In vitro DTI image analyses were performed at both mesoscopic (whole brain, anatomical regions 
of interest) and microscopic (voxel-wise) scales. First, voxel-wise tensor maps were calculated 
using the diffusion software toolbox (http://www. fmrib.ox.ac.uk/fsl/).50 Second, 3D voxel-wise 
tensor maps were spatially normalized by using the DTI-TK diffeomorphic deformable image 
registration algorithm (https://www.nitrc.org/projects/dtitk).51, 52 Finally, fractional anisotropy 
(FA), was calculated in the spatially normalized space for each subject. 
Voxel-wise statistical analyses were performed after smoothing the spatially normalized 
DTI indices by a 0.4 mm Gaussian smoothing kernel. A two-sample t-test was performed for 
animals in each age group using SPM12. A voxel was considered statistically significant at p-value 
< 0.05 after correcting for multiple comparison by FDR. Characterization of anatomically defined 
regions of interest (ROI) was performed using deterministic streamline fiber tractography.53 
Connectivity of WM tracts within corpus callosum (CC), anterior commissure (AC), and the 
projection fibers from CC to frontal cortex (FC) were manually delineated. ROIs were delineated 
by using whole-brain population averaged fiber tracts (Supplementary Figure 2). In addition, an 
image plane orthogonal to the long axis of the structure was created in evaluating the 2D slice 
profile of FA. 
Immunohistochemical analyses: 
All rats in the longitudinal MRI scan series underwent histological analysis for detection of fibrillar 
amyloid, neuroinflammation and CMB. Immunohistochemistry and histology were performed as 
previously described and detailed in the supplemental method.40, 54-56 
Statistical analysis: 
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The data are presented as mean estimates or differences of means for the tissue compartment 
outcomes with standard deviations (SD) for univariate summaries or standard errors (SE) 
otherwise. Designed experiments that yielded one measurement per rat were analyzed using linear 
regression analysis. For experiments with repeated measurements on each animal, we used a 
Generalized Estimating Equations (GEE) to account for repeated measures correlations. All 
hypotheses were tested using Wald test statistics. Pairwise comparisons between the two strains at 
each age were investigated. The p-values were not adjusted for multiple comparisons. All 
hypothesis tests and 95 % confidence intervals (CI) are two-sided. Analyses were performed using 
the Stata (version 16.1) statistical package. Additional statistical analysis was carried out using 
XLSTAT statistical and data analysis solution. (Boston, USA. https://www.xlstat.com). Cohen’s 
d was also calculated in the voxel-wise analyses as a measure of effect size.57, 58
Results
In all anesthetized rats, oxygen saturation (SpO2) and heart rate were measured continuously 
during the ~1h MRI scan and these data for each of the four scan sessions are presented in the 
Supplementary Figure 3. Statistical analysis on the influence of age and strain on SpO2 rate at the 
beginning (5-min) and end of the scans (55-min) revealed no differences across strains for either 
time point. For heart rate measures at the end of the scan, differences were significant for the 
variables age (p-value < 0.0001) and strain (p-value < 0.004) indicating that rTg-DI rats were 
hemodynamically more sensitive to the effect of anesthesia.
CAA type 1 pathology accelerates age-dependent white matter loss 
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Volumes for GM, WM and CSF tissue compartments of rTg-DI and WT rats at 3M, 6M, 9M and 
11M age points are summarized in Supplementary Table 1. For TIV, there was no significant 
differences between WT and rTg-DI rats as noted in the p-values for the tests of pairwise 
differences. For the GM compartment the statistical analysis revealed no volumetric differences 
between strains at any age. However, an overall ~10% GM volume loss was documented from 3M 
to 11M in both strains. (p-value < 0.001, Supplementary Table 1 and Figure 1). The temporal 
profiles of WM volume from rTg-DI and WT rats differed across the four age groups (p-value < 
0.001) and is also reflected in the four pairwise differences (Supplementary Table 1, p-values < 
0.001). Figure 1 shows the WM volume changes as a function of age and illustrates that the rTg-
DI and WT rats diverge between 6M and 9M, with a pairwise mean difference of -51.7 mm3 (95% 
CI = [-72.7, -30.7] cm3, p-value < 0.001). Note also, that the difference between the age-dependent 
WM volume profiles is largest at 11M (mean difference = -74.5 mm3 (95% CI = [-95.7, -53.4] 
cm3, p-value < 0.001) (Supplementary Table 1). 
VBM analyses were performed at the designated ages of 3M, 6M, 9M and 11M to further 
characterize the spatial distribution of local morphological differences between WT and rTg-DI 
rats. VBM analysis revealed no GM volume differences betwe n WT and rTg-DI rats at any age 
(Supplementary Figure 4). However, the VBM analysis on WM revealed striking strain differences 
as shown in Supplementary Figure 5. Note that in both WT and rTg-DI rats global volumetric WM 
maturational growth is apparent from 3M to 6M in agreement with the quantitative data 
(Supplementary Table 1 and Figure 1). While in the WT rats, WM density appeared constant from 
6M to 11M, rTg-DI rats exhibited extensive, diffuse WM volume loss at 9M and 11M 
(Supplementary Figure 5). To further validate the descriptive VBM analysis, statistical parametric 
maps (color coded for p-values) were overlaid onto a population averaged PDW images to display 
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areas with significant morphological differences between the two strains (Figure 2). At 3M, only 
a few small clusters were observed to be smaller in rTg-DI compared to WT rats. However, at 6M, 
significant WM loss was apparent in the CC, and the deep mesencephalic nuclei of rTg-DI when 
compared to WT control rats. Furthermore, at 9M and 11M, WM loss in rTg-DI rats was 
widespread and included the entire body of the CC, AC and internal capsule. In addition, WM loss 
in rTg-DI rats was also notable in the in globus pallidus, thalamus, and the central tegmental tract 
compared to WT rats. No voxels survived the statistical significance in the direction of WM 
volume greater in rTg-DI compared to WT rats.
In vitro DTI analysis and histology confirms WM damage in rTg-DI CAA type 1 rats 
Whole brain DTI image analyses focused on analyzing the key DTI index FA within the WM 
tissue compartment and FA values within the age groups for WT and rTg-DI rats are summarized 
in Supplementary Table 2. This analysis revealed that the mean FA was found to be significantly 
different at 9M and 11M of rTg-DI compared to age-matched WT. The voxel-wise FA analysis 
was performed at the four age groups separately, minor areas of significant differences between 
the two groups were observed at 9M (results not shown). At 11M widespread areas with significant 
group differences were found as shown in Figure 3. Largely consistent with the pattern of WM 
loss observed in vivo as shown in Figure 2, the rTg-DI rats displayed significantly reduced FA 
values (indicating impaired WM integrity) in several WM structures including CC, AC, fornix, 
internal capsule, reticular thalamic nuclei and deep mesencephalon. We also observed small focal 
areas with higher FA values in rTg-DI compared to WT rats (Figure 3). These focal FA increases 
in rTg-DI rats occurred near the ventral posteromedial thalamic nuclei (VPM) and gustatory 
thalamic nuclei suggesting enhanced anisotropy in these specific areas. 
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To evaluate topographical patterns of reduced FA within WM tracks including the CC, AC 
and the projection fibers from CC to FC between the two strains at 11M, we extracted and plotted 
their respective FA values along planes orthogonal to the long axis of the ROIs (Supplementary 
Figure 6). In normal WT rats, the FC projection fibers exhibited a monotonically decreasing trend 
as the slices became closer to the cortex (Supplementary Figure 6). Similarly, in normal WT rats, 
FA values within the AC, became lower as the slices approached the olfactory bulb. When 
comparing across strains, differences in FA values were noted to be slice dependent. For example, 
in the CC, substantial FA decreases (~15 %) in rTg-DI rats were found in the body of CC compared 
to WT rats, while FA values in the genu and splenium were within similar range (~2 %) for the 
two strains. In the AC, the anterior portion exhibited larger differences (~10 % lower in rTg-DI 
rats) compared to the posterior portion (~3 % lower in rTg-DI rats). In contrast, FC slice profiles 
were nearly identical across all slices except first several slices, which were positioned proximal 
to the body of CC which exhibited relatively high FA values (~0.4). In summary, the topographical 
analysis of FA changes in the pre-selected WM tracks showed that in rTg-DI rats, large portions 
of the CC body and the AC displayed WM loss while the genu of the CC and the FC were less 
effected. 
Myelin staining in brain sections from a parallel group of aged WT and rTg-DI rats 
revealed an obvious thinning and significant ~30 % reduction (p-value < 0.05) in the volume of 
the CC (Figure 4A-C). Similarly, quantitative measures showed a significant >40 % reduction (p-
value < 0.01) in myelin basic protein (MBP) levels in the CC of these rats further supporting the 
reduction in WM in this region (Figure 4D). Together, these pathological findings are highly 
consistent with WM loss observed in the MR imaging (Figures 1, 2 and 3). Supplementary Figure 
7 presents immunohistochemical labeling of axons with the pan-axonal neurofilament marker 
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SM312 to further validate the MRI and histopathology data by documenting differences in normal 
and pathological axons in several WM regions in 11M WT and rTg-DI rats. Guided by the MRI 
results of WM damage we focused on documenting axonal pathology in the CC (body and genu) 
and thalamus. At 11M of age obvious strain differences were noted between WT and rTg-DI rats 
(Supplementary Figure 7B-I). First, thinning of the CC above the dorsal hippocampus in the 11M 
rTg-DI rats compared to WT was clearly discernable (Supplementary Figure 7B, F). Second, in 
11M rTg-DI rats, general axonal loss was evident throughout the body of the CC compared to 11M 
WT (Supplementary Figure 7C, G). Also, in the genu of the CC, axonal density did not appear to 
be affected, however, general disintegration (i.e. shorter axonal segments and lack of axonal 
coherence) was noted in the in rTg-DI rats compared to WT rats (Supplementary Figure 7D, H). 
Finally, in the thalamus, axonal density was reduced, and axonal directional pattern appeared 
disrupted in the 11M in rTg-DI rats when compared to WT (Supplementary Figure 7E, I). 
Thalamic and cortical T2* hypointensities emerge at 6M in rTg-DI rats 
T2* maps of the brain reflect local magnetic susceptibility and are therefore sensitive for detecting 
blood products and other macro- or microscopic inhomogeneities within a given tissue 
compartment.59-61 We used T2* maps primarily for detecting evolution of thalamic CMB in the 
rTg-DI rats over time. Color-coded T2* maps as shown in Figure 5A anatomically distinguish 
WM regions (e.g. CC, fimbria, internal capsule and cerebellar WM) from GM regions due to 
myelin’s inherently lower transverse relaxation time (WM T2* ~25 ms, green colors). Second, 
when comparing T2* brain maps of WT to rTg-DI rats, the most striking abnormalities are the 
bilateral, symmetrical thalamic T2* hypo-intensities. Third, areas in cortex also exhibited reduced 
T2* differences between the two strains. Specifically, column-shaped hypointensities began to 
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manifest at 6M in rTg-DI rats and became progressively more prominent with aging but were 
mostly absent in WT rats (Supplementary Figure 8). The column-shaped T2* hypo-intensities 
penetrated the entire cortex and appeared to merge with CC. Voxel-wise T2* analyses were 
performed to identify areas with statistically significant age-dependent T2* differences between 
WT and rTg-DI rats. Figure 5B shows the statistical parametric maps at 3M, 6M, 9M and 11M of 
significantly reduced T2* values in rTg-DI compared to WT rats (with color-coded p-values) 
overlaid onto a population averaged anatomical PDW template. At 3M no differences were found 
in T2* between the two strains. However, at 6M significantly reduced T2* values were observed 
within the ventral posterolateral (VPL) and ventral posteromedial (VPM) nuclei and these thalamic 
areas grew in size at 9M and 11M to encompass the entire thalamus. Thalamic, focal hypointense 
lesions were apparent on T2* in 100% of the rTg-DI rats at 11M of age. In rTg-DI but not WT 
rats, significant widespread T2* reductions in the cortices were also evident at 9M and 11M 
(Figure 5). Figure 6 shows the age-dependent trajectories of (1) total thalamic CMB load in rTg-
DI rats from 3M to 11M as evaluated by T2* values (Figure 6A), (2) age-dependent CMB volume 
growth derived from calculating voxels with T2* values ≤ 20ms within the thalamus (Figure 6B) 
in comparison to WT rats. In agreement with voxel-wise analysis statistical analysis of age-
dependent CMB load trajectories from the two strains based on T2* shows that their profiles 
(curves) are different across the age groups (p-value < 0.0001, Figure 6, Supplementary Table 3). 
Specifically, based on T2* data CMB starts emerging at 6M in rTg-DI rats (Figure 6A). Based on 
volumetric assessment CMB emerge at 6M and at 11M CMB volume in rTg-DI rats averaged ∼7 
mm3. Of note, the T2* threshold of ≤ 20ms for quantifying CMB was set empirically based on 
‘best match’ of the focal hypo-intense lesions observed bilaterally in thalamus, and very small 
CMB might not be captured by this approach.





























































Confidential: For Review Only
16
We also confirmed the presence of thalamic CMB in all rTg-DI rats at 11M as defined by 
Prussian blue iron staining for perivascular hemosiderin deposits (Figure 6F). In the longitudinal 
cohort of rTg-DI rats, CMB were observed within the VPM/VPL thalamic nuclei bilaterally 
(Figure 6C-G). In all rTg-DI rats petechial Prussian blue positive deposits were observed to be 
diffusely dispersed in the thalamus and in the majority of rTg-DI rats numerous occluded and 
calcified microvessels were also evident (Figure 6F, G). Prussian blue positive ferritin products 
were not observed in the cortex (not shown) including areas associated with the column-shaped 
hypointense signal on the T2* maps (Supplementary Figure 8). In a subset of 11M old rTg-DI rats 
the % area fraction of hemosiderin was measured in the thalamus revealing 2.01 ± 0.70% (n = 4; 
SD) for hemosiderin coverage in this region, consistent with previous findings.40
Given the clinical literature associating vascular amyloid deposition with CMB and the 
Boston criteria for CAA diagnosis62, 63 we also investigated amyloid deposition patterns in 11M 
old rTg-DI rats in pre-selected areas (Figure 7). Perivascular capillary Aβ deposits in rTg-DI rats, 
were abundant in cortex, hippocampus and thalamus (Figure 7C-E). Further, the microvascular Aβ 
deposits were strikingly dense in the thalamic region (Figure 7E) when compared to the cortex and 
hippocampus (Figures 7C, D). Further, quantification of the % area capillary amyloid coverage 
confirmed the high level of perivascular capillary Aβ deposits in thalamus (Figure 7F). Thus, the 
emergence of CMB in the thalamic region is likely associated with the heavy microvascular Aβ 
burden in this region. As expected, perivascular neuroinflammation in form of astrogliosis and 
activated microglia in rTg-DI rats was also pervasive in 11M rTg-DI rats in regions with heavy 
microvascular amyloid burden such as the thalamus and hippocampus in comparison to WT 
(Supplementary Figure 9). Astrocytes appeared to be increased in number and volume in 11M rTg-
DI rats (Supplementary Figure 9E-H) when compared to 11M WT rats (Supplementary Figure 9A-
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D). In the hippocampus and thalamus of WT rats Iba 1-positive microglia were sparse in numbers 
and exhibited the resting, surveillance phenotype with long extended processes (Supplementary 
Figure 9K, L). In contrast, in 11M rTg-DI rats the number of microglia in hippocampus and 
thalamus was increased and the microglia phenotype was activated with the characteristic enlarged 
cell bodies and retracted processes (Supplementary Figure 9O, P). 
Discussion
The contribution of CAA pathology to subcortical WM disease is a critical question to 
address for understanding the role of CAA in the pathogenesis of VCID and AD.64-66 The overlap 
of clinical symptoms between AD nd CAA poses significant challenges for understanding their 
respective contributions to VCID and ultimately for advancing preventive and novel therapeutics. 
Here we used our novel rTg-DI transgenic rat model of the CAA-type 140 in combination with 
advanced MRI and histological measures to show that evolving CAA type 1 pathology, including 
CMB, is associated with WM disease. The demonstrated reliability of MRI measures of WM 
disease with aging makes in vivo MRI studies of the rTg-DI rat model ideal for studying CAA type 
1 in isolation without other comorbidities like hypertension or other AD pathologies. Further, the 
4-fold larger brain size in comparison with the mouse brain allows improved anatomical resolution 
using in vivo MRI. 
To execute the longitudinal in vivo MRI study, we combined two time-efficient sequences 
designed to track morphometry as well as CMB. We used a PDW sequence for WM and GM 
morphometric analysis similar to our previous study on spontaneously hypertensive rats44 and for 
CMB load we implemented a multiple gradient echo sequence to derive T2* maps allowing for 
quantitative age-dependent comparisons across animals and groups. We further validated WM loss 
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by implementing in vitro DTI on separate series of rTg-DI and WT rats to assess WM integrity via 
FA analysis. The morphometric quantitative in vivo data showed that rTg-DI rats (but not WT 
controls) started developing WM loss in the CC at 6M, which rapidly progressed at 9M and 11M 
into a specific pattern of WM loss incorporating the entire body of the CC, internal capsule, AC, 
thalamus and midbrain. The WM loss documented in vivo was confirmed by in vitro DTI and 
histology. Remarkably, in spite of massive perivascular Aβ deposition and neuroinflammation in 
cortex, hippocampus and thalamus the rTg-DI rats did not exhibit more significant age-dependent 
GM loss when compared to WT controls at any time point. We also demonstrated that CMB 
emerged at 6M in the thalamus in rTg-DI rats and dramatically expanded in thalamus at 9M and 
11M. The total thalamic CMB volume was not strongly associated with total WM loss in rTg-DI 
rats (results not shown). 
Cerebral microbleeds (CMB) in CAA type 1 rTg-DI rats
According to the Boston criteria, the key diagnostic imaging features related to a probable case 
of CAA pathology in humans, is the presence of cerebral micro/macrohemorrhages.28, 62 CAA 
related hemorrhage is thought to result from excessive vascular Aβ deposits leading to 
structurally brittle vessels that are unable to withstand changes in blood pressure.67 An alternate 
hypothesis states that increased expression of proteolytic enzymes contributes to CMB by 
disrupting the vessel wall in CAA.25 In support of clinical data linking CAA pathology with 
cerebral hemorrhage, in the rTg-DI rats CMB emerged in the thalamus which also exhibited the 
most extensive deposition of microvascular fibrillar Aβ. A dense network of capillaries with 
microvascular amyloid was evident in thalamus when compared to cortex and hippocampus. 
Other reasons for the susceptibility of the thalamus to microvascular Aβ deposition and CMB 
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should be noted. In rodents the thalamus is proportionately larger than other brain regions 
compared with the proportions in the human brain. Therefore, it seems more plausible that 
perivascular Aβ accumulation including microbleeds will emerge in the rodent in the thalamus. 
Another possibility for extensive perivascular Aβ accumulation in the thalamus may be related to 
patterns of glymphatic transport flow and waste drainage which has been shown to be less 
efficient in deep regions such as the thalamus.68-70
In the rTg-DI rats, CMB as defined by lower T2* values was observed to emerge at 6M in 
the ventral posteromedial and posterolateral thalamic nuclei. CAA type 1 (as documented in this 
study) is not the only cSVD associated with thalamic CMB. In patients with genetic forms of 
CADASIL ~50 % have microbleeds and these are mostly in the deep structures including 
thalamus.71, 72 In clinical cases of sporadic cSVD the pattern and prevalence of CMB varies with 
the underlying type of cerebral angiopathy, its severity and age of patient, but in general up to 
about 20 % of patients with sporadic cSVD have a CMB somewhere.73 The Boston criteria state 
that microbleeds at the cortical grey-white matter junction (so-called lobar microbleeds) indicate 
CAA whereas those in deep structures like thalamus, internal capsule, lentiform and caudate nuclei 
indicate hypertensive small vessel pathology. However, in human CAA, although there are often 
many lobar microbleeds, there are often microbleeds in the deep structures including thalamus 
(personal observation, Dr. Wardlaw). Of note, CMB are also observed in the thalamus in 
preference to other sites in other rodent cSVD models for example the carotid coil hypoperfusion 
models74 and in the APP23 mouse model.75 
We observed column-shaped T2* hypo-intensities in the somatosensory cortex of rTg-DI 
rats which were not associated with histological evidence of hemorrhage and therefore must be 
attributed to alternate pathophysiology. Quantitative T2* maps reflect local magnetic 
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susceptibility within a given tissue compartment which can be affected by a variety of physical 
and physiological effects including iron deposition, deoxyhemoglobin, low tissue oxygenation 
levels, high myelin content, vessel dilation, capillary tortuosity, and/or dense core parenchymal 
Aβ plaques.60, 76-78 As we excluded iron deposition by histology and the absence of dense core Aβ 
plaques in the rTg-DI rats, alternative explanations should be explored. The cortical column-
shaped T2* hypo-intensities could signify vascular remodeling/dilation related to the CAA type 1 
pathology.40, 79 Given that most of the column-shaped hypo-intensities appeared in somatosensory 
cortex including barrel cortex it is reasonable to suggest that they might represent diaschisis of 
cortical functional column/units in form of secondary damage due to the thalamic CAA and CMB 
involving VPM and VPL.80 In this context it is noteworthy that rTg-DI mice and rats display early 
signs of deficit in the novel exploration behavioral tasks.40, 55 In this particular test the rodents are 
placed in an open field to explore for novel and distinct objects of a short trial period, and the rTg-
DI rats exhibit slowing in the manner of exploration of the unique objects suggesting perceptual 
slowing.40 This behavioral phenotype could be explained by the lack of major input they would 
use in exploring new environment and stimuli (e.g. projections from the thalamic VPM to barrel 
cortex).
Diffuse white matter loss in rTg-DI rats
WM degeneration detected by VBM and DTI analyses was robustly observed in rTg-DI 
rats around 9M of age and included CC, internal capsule, AC, thalamus and midbrain. 
Topographical WM differences between the two strains detected by the morphometric VBM 
analysis based on PDW images and FA based DTI maps were noted. Both modalities consistently 
yielded WM compromise in CC, AC, certain parts of thalamus and midbrain (Figure 2 and Figure 
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3) in rTg-DI compared to WT rats. The loss of WM in the CC observed by imaging was supported 
by histological myelin staining as well as by direct measurement of MBP levels in the CC 
supporting the overall analysis and conclusions. However, the extent of WM damage in thalamus 
and midbrain was different which is likely due to the different parametric measure. The FA 
parameter is sensitive to loss of WM integrity in pure WM areas and thalamus, the latter of which 
is a mix of WM and GM, which is therefore an area with inherently lower FA values in normal 
brain. On the other hand, the VBM analysis based on PDW contrast includes the entire thalamus 
in the WM template, was more sensitive to WM loss and detected difference at 9M as well as 11M. 
In addition axonal loss and disruption of WM tracts including the CC and thalamus was confirmed 
by the SM312 pan axonal neurofilament marker (Supplementary Figure 7). The progressive WM 
loss and CMB load in thalamus in the rTg-DI rats affect their cognitive function. In the recent 
study by Popescu and colleagues, a comprehensive age-dependent analysis of cognitive function 
and behavior in the rTg-DI and WT rats was described using a battery of behavioral tasks.81 In this 
study WT and rTg-DI rats were first evaluated at 3M of age and habituated to operant training; 
with data collection beginning at 6M (when microvascular amyloid starts becoming more 
extensive) and continuing for 4M until a final evaluation at 12M when microvascular Aβ is severe 
and WM loss significant.81 The behavioral task performance analysis revealed a general ‘slowing’ 
of cognition (rather than deficient memory capacity) starting at 7M in the rTg-DI rats which 
progressively worsened.81 Specifically, cognitive assessments showed that rTg-DI rats interacted 
with their environment more hesitantly and perform ‘slower’ when compared to WT rats consistent 
with thalamo-cortical dysfunction impacting sensorimotor integration.
We explored the possible mechanisms which might underlie WM loss in the rTg-DI rats. 
First, WM structures in the rTg-DI rats such as the CC and AC exhibited neither CMB, excessive 
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Aβ deposition nor neuroinflammation indicating that axonal damage was not directly related to 
either of these pathologies in contrast to what was recently reported in a mouse model of pericyte 
degeneration.82 The temporal trajectory of CMB and WM damage suggested that WM damage 
succeed the thalamic CMB. However, statistical analysis did not support strong association 
between thalamic CMB and WM loss which might be attributed to a small sample size combined 
with a noisy CMB readout signal from the T2* maps. Future studies will need to further explore a 
potential association between these two parameters. Regardless, the anatomical specificity of WM 
loss in the CC, AC and midbrain suggest that it is either secondary (or Wallerian) to the thalamic 
CMB similar to what is reported in CADASIL patients.71, 72, 83
In summary, white-matter hyperintensities is a well establish imaging feature of normal 
aging in human and its burden is also associated with cSVD and CAA.8, 84 However, until now it 
has been unclear if CAA pathology alone may contribute to WM degeneration since clinical cases 
of CAA most often overlap with other cSVD subtypes or AD. Our study now provides novel 
evidence that CAA type 1 pathology can lead to significant WM loss and degeneration and the 
extent of WM loss is likely to underly the early behavioral deficits observed in rTg-DI rats. The 
evidence of WM loss in CAA is important because long range cortical projection fibers are of great 
interest in understanding VCID in cSVD.10, 85, 86 The present findings further underscore the utility 
of rTg-DI rats to further explore the mechanistic basis of WM degeneration in CAA.
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Titles and legends to figures
Figure 1: Significantly greater white matter loss observed in rTg-DI compared to WT rats 
Mean and 95 % confidence bands for age-dependent volumetric changes of the grey matter (GM) 
(A), white matter (WM) (B) for WT (blue, filled circles) and rTg-DI rats (red, filled circles) 
extracted from proton-weighted magnetic resonance images acquired in vivo. Observations for the 
WT group have been shifted slightly left of the rTg-DI group at each age to more clearly display 
the data. Individual filled circles represent individual rats. Model estimates are presented as means 
(filled squares) with 95% pairwise confidence intervals (black bands) using Generalized 
Estimating Equations (GEE). Mean differences were tested for rTg-DI vs WT groups at each age 
group. For the GM compartment, the results revealed no significant volumetric differences 
between strains tested at each age. For WM volume, the mean profiles between rTg-DI and WT 
rats differed statistically across the age groups (p-value < 0.001).
Figure 2: Age-dependent WM loss occurs in a specific anatomical pattern in rTg-DI rats
(A) Spatially normalized population averaged WM volumetric maps of 11 month (M) old rTg-DI 
and WT rats are shown in color maps, highlighting extensive WM loss in 11M rTg-DI rats 
compared to WT. (B) For each age group, statistical parametric maps (color coded for p-values) 
were calculated at p-value < 0.05 after FDR multiple comparison correction and overlaid onto 
population averaged proton density weighted MRI images to display anatomical areas with 
significant white matter (WM) loss in rTg-DI in comparison to WT rats. Cohen’s d represents the 
effect size. Anatomical levels of the axially displayed anatomical templates are given by their 
nearest Bregma distance. At 3M and 6M only the corpus callosum (CC) and deep mesencephalic 
nuclei (DpMe) were significant for WM loss in the rTg-DI rats. However, at 9M and 11M, 
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significant WM loss in rTg-DI rats was widespread and included the CC, globus pallidus (GP), 
internal capsule (IC), thalamus and central tegmental tract (ctg). Scale bar = 15 mm.
Figure 3: WM loss in rTg-DI rats with late stage disease validated by in vitro DTI
A: Anatomical templates based on FA contrast are shown to highlight landmarks. Anatomical 
landmarks of the templates are indicated by their nearest Bregma distance. Anatomical structures 
of relevance are as follows: CC = Corpus Callosum; LS = Lateral Septum; AC = Anterior 
Commissure; Cpu = Caudate Putamen; IC = Internal Capsule; f = fornix; mt = mammillothalamic 
tract; VPM = Ventral posteromedial thalamic nuclei; Rt = reticular thalamic nuclei; DpMe = Deep 
mesencephalic nuclei; SNR = Substantia Nigra; VTA = Ventral Tegmental Area; Hip = 
Hippocampus; ctg = central tegmental area. B: Brain areas where FA values are significantly 
different (color coded for p-values) in 11M old rTg-DI rats compared to the age-matched WT rats 
are shown. Cohen’s d represents the effect size. Scale bar = 15 mm.
Figure 4: Myelin loss in the corpus callosum of rTg-DI rats
Representative sagittal sections from 11 M old WT rat (A) and rTg-DI rat (B) stained for myelin 
showing a reduction in the size of the corpus callosum. Scale bars = 1000 µm. (C) Stereological 
quantitation of the corpus callosum volume from 11 M WT (black dots) and rTg-DI (red dots) rats. 
Data shown are the mean ± SD of n =3 rats per group; p-value < 0.05. (D) The corpus callosum in 
11 M WT and rTg-DI rats was collected by laser capture microscopy and MBP levels were 
determined by quantitative immunoblotting. Data shown are the mean ± SD of n = 3 rats per group; 
p-value < 0.01.





























































Confidential: For Review Only
34
Figure 5: Brain areas with reduced T2* values in rTg-DI compared to WT rats
A: Spatially normalized population averaged color-coded T2* maps of 11M old rTg-DI and WT 
rats. Blue and red colors represent low and high T2* values, respectively. Significantly reduced 
T2* values (white arrows) in the thalamus is suggestive of blood products. B: Voxel-wise T2* 
analyses were performed to quantify areas with statistically significant T2* differences between 
WT and rTg-DI rats at 3M, 6M, 9M and 11M of age. The statistical parametric maps of 
significantly reduced T2* values in rTg-DI rats compared to WT rats (with color-coded p-values) 
are overlaid onto a population averaged anatomical PDW template and shows changes in thalamus 
(ventral posteromedial nucleus (VPM)), subiculum (subic), and in the somatosensory cortices. 
Cohen’s d represents the effect size. Scale bar = 15 mm.
Figure 6: Thalamic microbleeds by T2* emerge at 6M in rTg-DI rats
A: Age-dependent trajectories of the total thalamic CMB load in rTg-DI rats from 3M to 11M as 
evaluated by mean T2* values. Blue and red filled circles represent WT and rTg-DI rats, 
respectively. Statistical analyses show that age-dependent trajectories of the two strain are 
statistically different with respect to the age groups (p-value < 0.0001). A distinct difference 
between mean T2* data is present at 6M in rTg-DI rats: mean T2* is 1.8 ms lower than WT rats, 
(p-value = 0.001). B: Age-dependent CMB volume derived based on number of voxels with T2* 
values ≤ 20 ms within the thalamus in comparison to WT rats. Blue and red filled circles represent 
WT and rTg-DI rats, respectively. Rapid CMB growth is apparent at 9M and onwards in rTg-DI 
rats (p-values for pairwise mean differences at both 9M and 12M < 0.001). Model estimates are 
presented as means (filled squares) with 95 % pairwise confidence intervals (black bands) using 
Generalized Estimating Equations (GEE). C: Anatomical proton-density weighted MRI from a 





























































Confidential: For Review Only
35
rTg-DI rat in the sagittal plane at the level of the dorsal hippocampus and thalamus. Thal = 
thalamus. D: Corresponding T2* map from the same rat shown in (C). The hypointense areas in 
the Thal are evident. E: Post-mortem histological stain for perivascular hemosiderin using Perl’s 
Prussian Blue stain. The black box depicts the magnified areas (F, G). F: Magnified area from the 
thalamus showing numerous small deposits hemosiderin deposits (indicated by blue arrows), many 
surrounding what appear to be occluded vessels. G: Numerous occluded and calcified microvessels 
were confirmed in the same thalamic area. Scale bars = 50 µm. 
Figure 7: Pattern of microvascular fibrillar Aβ deposition in 11M rTg-DI rats
A: Sagittal plane from a proton-density weighted MRI of a WT rat highlighting anatomical areas 
of interest: Cortex (Ctx), hippocampus (Hip) and thalamus (Thal). B: Sagittal brain section from a 
11M old rTg-DI immunolabeled with thioflavin S (ThS) to identify fibrillar amyloid (green). The 
white boxes highlight the anatomical areas magnified in C-E which are sections from these areas 
now immunolabeled with rabbit polyclonal antibody to collagen IV to specifically detect cerebral 
microvessels (red) and stained with ThS to identify fibrillar amyloid (green). The microvascular 
amyloid deposits are clearly present in Ctx (C), in the hilus region of the hippocampus (D) and in 
the thalamus (E). Scale bars = 50 µm. (F) The quantitation of microvascular amyloid load in the 
three brain regions confirming the thalamic area is most heavily affected.
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Figure 1: Significantly greater white matter loss observed in rTg-DI compared to WT rats 
Mean and 95 % confidence bands for age-dependent volumetric changes of the grey matter (GM) (A), white 
matter (WM) (B) for WT (blue, filled circles) and rTg-DI rats (red, filled circles) extracted from proton-
weighted magnetic resonance images acquired in vivo. Observations for the WT group have been shifted 
slightly left of the rTg-DI group at each age to more clearly display the data. Individual filled circles 
represent individual rats. Model estimates are presented as means (filled squares) with 95% pairwise 
confidence intervals (black bands) using Generalized Estimating Equations (GEE). Mean differences were 
tested for rTg-DI vs WT groups at each age group. For the GM compartment, the results revealed no 
significant volumetric differences between strains tested at each age. For WM volume, the mean profiles 
between rTg-DI and WT rats differed statistically across the age groups (p-value < 0.001). 
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Figure 2: Age-dependent WM loss occurs in a specific anatomical pattern in rTg-DI rats 
(A) Spatially normalized population averaged WM volumetric maps of 11 month (M) old rTg-DI and WT rats 
are shown in color maps, highlighting extensive WM loss in 11M rTg-DI rats compared to WT. (B) For each 
age group, statistical parametric maps (color coded for p-values) were calculated at p-value < 0.05 after 
FDR multiple comparison correction and overlaid onto population averaged proton density weighted MRI 
images to display anatomical areas with significant white matter (WM) loss in rTg-DI in comparison to WT 
rats. Cohen’s d represents the effect size. Anatomical levels of the axially displayed anatomical templates 
are given by their nearest Bregma distance. At 3M and 6M only the corpus callosum (CC) and deep 
mesencephalic nuclei (DpMe) were significant for WM loss in the rTg-DI rats. However, at 9M and 11M, 
significant WM loss in rTg-DI rats was widespread and included the CC, globus pallidus (GP), internal capsule 
(IC), thalamus and central tegmental tract (ctg). Scale bar = 15 mm. 
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Figure 3: WM loss in rTg-DI rats with late stage disease validated by in vitro DTI 
A: Anatomical templates based on FA contrast are shown to highlight landmarks. Anatomical landmarks of 
the templates are indicated by their nearest Bregma distance. Anatomical structures of relevance are as 
follows: CC = Corpus Callosum; LS = Lateral Septum; AC = Anterior Commissure; Cpu = Caudate Putamen; 
IC = Internal Capsule; f = fornix; mt = mammillothalamic tract; VPM = Ventral posteromedial thalamic 
nuclei; Rt = reticular thalamic nuclei; DpMe = Deep mesencephalic nuclei; SNR = Substantia Nigra; VTA = 
Ventral Tegmental Area; Hip = Hippocampus; ctg = central tegmental area. B: Brain areas where FA values 
are significantly different (color coded for p-values) in 11M old rTg-DI rats compared to the age-matched WT 
rats are shown. Cohen’s d represents the effect size. Scale bar = 15 mm. 
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Figure 4: Myelin loss in the corpus callosum of rTg-DI ratsRepresentative sagittal sections from 11 M old WT 
rat (A) and rTg-DI rat (B) stained for myelin showing a reduction in the size of the corpus callosum. Scale 
bars = 1000 µm. (C) Stereological quantitation of the corpus callosum volume from 11 M WT and rTg-DI 
rats. Data shown are the mean ± SD of n =3 rats per group; p < 0.05. (D) The corpus callosum in 11 M WT 
(black dots) and rTg-DI (red dots) rats was collected by laser capture microscopy and MBP levels were 
determined by quantitative immunoblotting. Data shown are the mean ± SD of n = 3 rats per group; p < 
0.01. 
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Figure 5: Brain areas with reduced T2* values in rTg-DI compared to WT rats 
A: Spatially normalized population averaged color-coded T2* maps of 11M old rTg-DI and WT rats. Blue and 
red colors represent low and high T2* values, respectively. Significantly reduced T2* values (white arrows) 
in the thalamus is suggestive of blood products. B: Voxel-wise T2* analyses were performed to quantify 
areas with statistically significant T2* differences between WT and rTg-DI rats at 3M, 6M, 9M and 11M of 
age. The statistical parametric maps of significantly reduced T2* values in rTg-DI rats compared to WT rats 
(with color-coded p-values) are overlaid onto a population averaged anatomical PDW template and shows 
changes in thalamus (ventral posteromedial nucleus (VPM)), subiculum (subic), and in the somatosensory 
cortices. Cohen’s d represents the effect size. Scale bar = 15 mm. 
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Figure 6: Thalamic microbleeds by T2* emerge at 6M in rTg-DI rats 
A: Age-dependent trajectories of the total thalamic CMB load in rTg-DI rats from 3M to 11M as evaluated by 
mean T2* values. Blue and red filled circles represent WT and rTg-DI rats, respectively. Statistical analyses 
show that age-dependent trajectories of the two strain are statistically different with respect to the age 
groups (p-value < 0.0001). A distinct difference between mean T2* data is present at 6M in rTg-DI rats: 
mean T2* is 1.8 ms lower than WT rats, (p-value = 0.001). B: Age-dependent CMB volume derived based 
on number of voxels with T2* values ≤ 20 ms within the thalamus in comparison to WT rats. Blue and red 
filled circles represent WT and rTg-DI rats, respectively. Rapid CMB growth is apparent at 9M and onwards 
in rTg-DI rats (p-values for pairwise mean differences at both 9M and 12M < 0.001). Model estimates are 
presented as means (filled squares) with 95 % pairwise confidence intervals (black bands) using Generalized 
Estimating Equations (GEE). C: Anatomical proton-density weighted MRI from a rTg-DI rat in the sagittal 
plane at the level of the dorsal hippocampus and thalamus. Thal = thalamus. D: Corresponding T2* map 
from the same rat shown in (C). The hypointense areas in the Thal are evident. E: Post-mortem histological 
stain for perivascular hemosiderin using Perl’s Prussian Blue stain. The black box depicts the magnified areas 
(F, G). F: Magnified area from the thalamus showing numerous small deposits hemosiderin deposits 
(indicated by blue arrows), many surrounding what appear to be occluded vessels. G: Numerous occluded 
and calcified microvessels were confirmed in the same thalamic area. Scale bars = 50 µm. 
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Figure 7: Pattern of microvascular fibrillar Aβ deposition in 11M rTg-DI ratsA: Sagittal plane from a proton-
density weighted MRI of a WT rat highlighting anatomical areas of interest: Cortex (Ctx), hippocampus (Hip) 
and thalamus (Thal). B: Sagittal brain section from a 11M old rTg-DI immunolabeled with thioflavin S (ThS) 
to identify fibrillar amyloid (green). The white boxes highlight the anatomical areas magnified in C-E which 
are sections from these areas now immunolabeled with rabbit polyclonal antibody to collagen IV to 
specifically detect cerebral microvessels (red) and stained with ThS to identify fibrillar amyloid (green). The 
microvascular amyloid deposits are clearly present in Ctx (C), in the hilus region of the hippocampus (D) 
and in the thalamus (E). Scale bars = 50 µm. (F) The quantitation of microvascular amyloid load in the three 
brain regions confirming the thalamic area is most heavily affected. 
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